Form 4 for TYRA Tyra Biosciences, Inc.
Accepted 2022-09-08 00:00:00 ET · period of report 2022-09-06 · accession 0001209191-22-049219 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-09-08 | 2022-03-15 | TYRA | van den Boom Esther | CFO | A - Grant | $8.53 | +1,800 | 120.4K | +2% | +$15.4K |
| DM | 2022-09-08 | 2022-09-06 | TYRA | van den Boom Esther | CFO | A - Grant | $0.00 | +194.1K | 105.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-15 | A | A | 1,800 | $8.53 | 120,445 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-09-06 | A | A | 89,054 | $0.00 | 89,054 | D | $7.14 · — to 2032-09-05 | 89,054 Common Stock | (F4) 1/36th of the shares subject to the option vest monthly following September 6, 2022, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date. |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-09-06 | A | A | 105,000 | $0.00 | 105,000 | D | $7.14 · — to 2032-09-05 | 105,000 Common Stock | (F3) 1/48th of the shares subject to the option vest monthly following September 6, 2022, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date. |